Vivance
PrivateLast Round
Series B
Sep 13, 2023
Total Funding Raised
$60M
Company Overview
Vivance is a healthcare technology company that develops ultraportable dialysis devices and digital solutions for chronic kidney disease management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vivance Comparables
Compare Vivance with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Byonyks | 83% | |
| Diality | 81% | |
| Triomed AB | 79% | |
Vivance Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Sep 13, 2023 | ||||
| Series A | Dec 12, 2019 | ||||
| VC Round | Dec 1, 2016 |
Key People
Founding team and executive leadership
Vivance Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Eckuity | Series B |
| SEEDS Capital | Series A |
| Lion X Fund | Series B |
| Vickers Venture Partners | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2023
$20M round led by Lion X Fund and Vickers Venture Partners.
- Dec 12, 2019
$40M round led by Vickers Venture Partners.
Vivance Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Vivance's valuation, stock price, and market status.